Advisors - AIM-HI Accelerator Fund

Webster K. Cavenee, Ph.D.

Director of Strategic Alliances, Ludwig Institute for Cancer Research

Since 2015, Dr. Cavenee is Director, Strategic Alliances-CNS of Ludwig Cancer Research with global responsibilities. He is also Distinguished Professor of Medicine at the University of California, San Diego.

Cristina Campabadal

President & CEO, CCS Finanzas

Cristina Campabadal is the founding President and CEO of the CCS Finanzas, a financial services firm, helping high net worth Latam and Iberian families with their investments and wealth since…

Carlo M. Croce, M.D.

Professor of Internal Medicine, The Ohio State University

Dr. Croce entered the school of medicine of La Sapienza University of Rome and graduated in 1969 summa cum laude in medicine and Latin. He began his career in the…

Pamela Garzone, Ph.D.

Chief Medical Officer, Calibr, Scripps Research

Pamela Garzone, Ph.D., joined Calibr as Chief Medical Officer in May 2019, bringing decades of clinical research experience, spanning large pharmaceutical companies, biotech startups and academia...

Dimitra Georganopoulou, Ph.D.

Innovation Faculty, MIT linQ CATALYST

Dimitra currently serves on the Innovation Faculty of MIT linQ CATALYST. In this capaticy she mentors and guides innovators to accelerate and heighten the impact of their solutions on serious…

Raju Kucherlapati, Ph.D.

Paul C. Cabot Professor of Genetics, Professor of Medicine, Harvard Medical School

Since 2001 Dr. Kucherlapati is the Paul C. Cabot Professor of Genetics and Professor of Medicine at Harvard Medical School and was the first...

Jimmy Lu, MBA, J.D.

Managing Director, WI Harper Group

Mr. Jimmy Lu is a Senior Partner in the San Francisco office, bringing over 25+ years of high tech and venture capital experience. Having a background in technology investing, he…

Amy Millman

President & Co-Founder, Springboard Enterprises

Amy Millman is a passionate advocate for women entrepreneurs building Big Businesses Starting Small. In 2000, Amy co-founded Springboard Enterprises ...

Wenseng “Wendy” Pan, Ph.D.

Partner, Goodwin

Dr. Wenseng “Wendy” Pan, partner in Goodwin’s Technology & Life Sciences group, focuses on mergers and acquisitions, technology-based transactions, strategic partnerships and financing transactions...

Eifion Phillips, Ph.D., J.D.

Patent Attorney

A medicinal chemistry scientist turned patent attorney, Dr. Eifion Phillips has helped secure his clients’ intellectual property portfolios across various fields and innovations...

Kanaga Sabapathy, Ph.D.

Head, Division of Cellular and Molecular Research, National Cancer Center Singapore

Dr. Sabapathy obtained his Ph.D. in Molecular and Cellular Immunology from the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore, in 1995.

Paul Schimmel, Ph.D.

Professor, Department of Cell and Molecular Biology, The Scripps Research Institute

Paul Schimmel, Ph.D., is a biophysical chemist and he received his B.A. in biochemistry and biophysics from Ohio Wesleyan University in 1962...

Ashim Subedee, Ph.D.

Academic Innovation Lead, National Institutes of Health

Dr. Subedee currently serves as Program Director at the National Cancer Institute Small Business Innovation Research(SBIR) Development Center...

Thea Tlsty, Ph.D.

Professor of Pathology, University of California San Francisco

Dr. Thea Tlsty is Professor of Pathology at the University of California, San Francisco. She is known for her research in cancer biology, and her involvement in the discovery of…

Peter K. Vogt, Ph.D.

Professor of Molecular Medicine, Scripps Research Institute

Dr. Peter Vogt is a molecular biologist, virologist and geneticist. His research focuses on retroviruses and viral and cellular oncogenes.

Daniel D. Von Hoff M.D., F.A.C.P.

Physician-in-Chief & Distinguished Professor, Translational Genomics Research Institute

Daniel D. Von Hoff, M.D., F.A.C.P. FASCO, FAACR is currently Physician in Chief, Distinguished Professor at the Translational Genomics Research Institute (TGen) in Phoenix, Arizona.